Thomas Yau - Dept Med, Queen Mary Hosp

基本信息

浏览量：193

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 111 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Hepatitis B Virus (HBV) Infection on Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC)

Thomas Yau,Stephen Lam Chan, Robin Kate Kelley,Richard S. Finn,Changhoon Yoo,Junji Furuse,Zhenggang Ren, Heinz-Josef Kl Spacing Diaeresis Umpen,Masato Ozaka,Uwe Pelzer,Cagatay Arslan,Joon Oh Park,Julien Edeline, Juan W. Valle,Makoto Ueno,Arndt Vogel, Liis Starkopf,Usha Malhotra, Abby B. Siegel,Shukui Qin

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Nivolumab in Sorafenib-Naive and Sorafenib-Experienced Patients with Advanced Hepatocellular Carcinoma: 5-Year Follow-Up from CheckMate 040

A. B. El-Khoueiry,J. Trojan, T. Meyer,T. Yau,I. Melero, M. Kudo, C. Hsu,T. -y. Kim,S. -p. Choo,Y. -k. Kang,W. Yeo,A. Chopra,S. Soleymani, J. Yao,J. Neely,M. Tschaika,T. H. Welling,B. Sangro

ANNALS OF ONCOLOGYno. 4 (2024): 381-391

引用0浏览0WOS引用

Nivolumab Plus Ipilimumab Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: 5-Year Results from CheckMate 040

I. Melero,T. Yau,Y. -K. Kang,T. -Y. Kim, A. Santoro,B. Sangro, M. Kudo, M. -M. Hou, A. Matilla,F. Tovoli,J. Knox,A. R. He,B. El-Rayes,M. Acosta-Rivera,H. Y. Lim,S. Soleymani, J. Yao,J. Neely,M. Tschaika, C. Hsu,A. B. El-Khoueiry

ANNALS OF ONCOLOGYno. 6 (2024): 537-548

引用0浏览0WOS引用

Three-year Follow-Up Data from KEYNOTE-966: Pembrolizumab (pembro) Plus Gemcitabine and Cisplatin (gem/cis) Compared with Gem/cis Alone for Patients (pts) with Advanced Biliary Tract Cancer (BTC)

Richard S. Finn,Makoto Ueno,Changhoon Yoo,Zhenggang Ren,Junji Furuse, Robin Kate Kelley,Stephen Lam Chan,Julien Edeline,Heinz-Josef Klumpen,Thomas Yau,Chris Verslype,Masato Ozaka,Mohamed Bouattour,Joon Oh Park,Arndt Vogel, Juan W. Valle,Li Yu,Usha Malhotra, Abby B. Siegel,Shukui Qin

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) in patients (pts) with advanced biliary tract cancer (BTC): results from the randomized, double-blind phase 3 KEYNOTE-966 study

U. Pelzer,Kate R. Kelley,C. Yoo,R. S. Finn,J. Furuse, Z. Ren,T. Yau,H-J Klumpen,S. L. Chan,M. Ozaka,C. Verslype,M. Bouattour,J. O. Park,O. Barajas,J. W. Valle, L. Yu,U. Malhotra,A. B. Siegel,J. Edeline, M. Ueno, A. Vogel

ONCOLOGY RESEARCH AND TREATMENT (2023): 61-62

引用0浏览0引用

Autologous Cytotoxic T-cell Receptor T Cell Therapy (SCG101) Against Hepatitis B Surface Antigen Phase I/II Trial for Patients with Advanced Hepatitis B-related Hepatocellular Carcinoma

Ghassan K. Abou-Alfa,Wei-Peng Yong, Stephen Lam Chang, Jia Fan,Han Chong Toh,Thomas Yau,Supin Choo, Jing Wang,Nicole Kusuma,Christy Ma,Shukui Qin

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Abstract C149: Efficacy and Safety of Entrectinib in Patients (pts) with Locally Advanced/metastatic NTRK or ROS1 Fusion-Positive (fp) Solid Tumors, Not Evaluable for the Primary Endpoint of STARTRK-2

Stephen V Liu,Marc Peeters,Myung-Ju Ahn,Jessica J Lin,Yuichiro Ohe,Chung Cheung Thomas Yau,Walter Bordogna,Stuart Osborne,Sven Schwemmers,Harald Zeuner,Koichi Goto

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Supplementary Data from First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling As a Driver Event in Hepatocellular Carcinoma

Richard D. Kim,Debashis Sarker,Tim Meyer,Thomas Yau, Teresa Macarulla,Joong‐Won Park, Su-Pin Choo,Antoine Hollebecque, Max W. Sung,Ho-Yeong Lim,Vincenzo Mazzaferro, Joerg Trojan,Andrew X. Zhu, Jung‐Hwan Yoon,Sunil Sharma, Zhengyu Lin, Stephen L. Chan,Sandrine Faivre,Lynn G. Feun,Chia‐Jui Yen, Jean–François Dufour,Daniel H. Palmer,Josep M. Llovet,Melissa Manoogian,Meera Tugnait,Nicolas Stransky,Margit Hagel,Nancy E. Kohl,Christoph Lengauer,Cori Ann Sherwin,Oleg Schmidt‐Kittler,Klaus P. Hoeflich,Hongliang Shi,Beni B. Wolf,Yoon‐Koo Kang

openalex（2023）

引用0浏览0引用

100P Hepatitis B Virus (Hbv)-Related Outcomes in Patients (pts) with Baseline HBV Infection in the KEYNOTE-966 Study of Pembrolizumab (pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC)

S.L. Chan,R.S. Finn,J.W. Valle,R.K. Kelley,C. Yoo,J. Furuse, Z. Ren,T. Yau,H.J. Klumpen,M. Ozaka,C. Verslype,M. Bouattour,J.O. Park,J. Edeline, M. Ueno, A. Vogel, L. Yu,U. Malhotra,A.B. Siegel,S. Qin

Annals of Oncology (2023): S218

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn